1. Home
  2. OOMA vs YDES Comparison

OOMA vs YDES Comparison

Compare OOMA & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$20.02

Market Cap

517.6M

Sector

Technology

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.24

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
YDES
Founded
2003
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
517.6M
543.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
OOMA
YDES
Price
$20.02
$2.24
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$18.77
N/A
AVG Volume (30 Days)
314.1K
312.1K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
188.46
N/A
EPS
0.09
N/A
Revenue
$114,490,000.00
N/A
Revenue This Year
$20.35
N/A
Revenue Next Year
$4.17
N/A
P/E Ratio
$215.11
N/A
Revenue Growth
9.53
N/A
52 Week Low
$9.79
$1.70
52 Week High
$21.96
$25.00

Technical Indicators

Market Signals
Indicator
OOMA
YDES
Relative Strength Index (RSI) 55.63 44.84
Support Level $10.78 $2.14
Resistance Level $21.57 $3.05
Average True Range (ATR) 0.88 0.32
MACD -0.10 0.07
Stochastic Oscillator 52.24 59.36

Price Performance

Historical Comparison
OOMA
YDES

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: